Testing effectiveness (Phase 2)Looking for participantsNCT06858397
What this trial is testing
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
Who this might be right for
Fabry Disesase
GC Biopharma Corp 18